Prosecution Insights
Last updated: August 16, 2026

Duke University

83 pending office actions • 50 art units • 78 examiners • 0 of 83 (0%) have an AI response strategy ready • 80 patents granted in the last 365 days

Portfolio Summary

83
Total Pending OAs
49
Non-Final OAs
30
Final Rejections
4
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 26 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

14
Overdue
0
Due this week
8
Due this month
2
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 26 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (14)Due ≤ 30 days (8)Due ≤ 60 days (2)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

36
Hard (43%)
37
Medium (45%)
10
Easy (12%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other11 (13%)
§103 only27 (33%)
§102 only5 (6%)
§112 only7 (8%)
Double-patenting only3 (4%)
Double-patenting + other5 (6%)
Multi-statute (no §101)25 (30%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

53
Life Sciences
64% of docket
2
Information Tech
2% of docket
2
Communications
2% of docket
2
Semiconductors
2% of docket
12
Mechanical / Eng
14% of docket
12
Business / Other
14% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

830 h
Manual time on pending OAs
166 h
Time saved (low, 20%)
290 h
Time saved (mid, 35%)
7.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ORDAZ, CHRISTIAN JOSE 2 64.7% +91.7%
GILL, RACHEL B 2 65.4% +28.0%
FERNANDEZ, KATHERINE L 2 57.9% +38.1%
GRABER, JAMES J 2 45.9% +57.0%
LIPPOLIS, ALEXANDRA ROSE 2 39.3% +70.3%
BEGEMAN, ANDREW W 1 44.8% +22.1%
ALBERS, KEVIN S 1 24.5% +51.2%
JANOSKO, CHASITY PAIGE 1 17.5% +77.8%
FRENCH, CORRELL T 1 46.2% +33.5%
RIOS RUSSO, RAUL J 1 87.0% +8.8%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18757070 THREE-DIMENSIONAL MICROSTRUCTURE PROVIDING ADDITIONAL CURRENT-CARRYING PATHWAYS FOR SENSORS RIOS RUSSO, RAUL J 36d

Hard Cases (37)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17774329 TREATMENT FOR PRIMARY AND METASTATIC CANCER SALVOZA, M FRANCO G 24d overdue
18033002 COMPOSITIONS FOR AND METHODS OF CO-ANALYZING CHROMATIN STRUCTURE AND FUNCTION ALONG WITH TRANSCRIPTION OUTPUT BUNKER, AMY M 23d overdue
17265731 Enhanced Delivery of Drugs and Other Compounds to the Brain and Other Tissues DONOGHUE, BRITTNEY ERIN 23d overdue
18558211 COMBINATION THERAPIES FOR THE TREATMENT OF CANCER RAO, SAVITHA M 10d overdue
16632226 COMPOSITIONS AND METHODS COMPRISING SELF-ASSEMBLING PEPTIDE-POLYMER NANOFIBERS FOR SUBLINGUAL IMMUNIZATION STEELE, AMBER D 4d overdue
18757189 Compositions and Methods for Safeguarding Plant Immunity Response to Elevated Temperatures ORDAZ, CHRISTIAN JOSE 3d overdue
18962035 NON-INVASIVE ORTHOSIS FOR IMMOBILIZING THE CERVICAL SPINE ALBERS, KEVIN S 14d
17637760 COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL PAIN AND ITCH GRABER, JAMES J 15d

Interview Candidates (14)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18757189 Compositions and Methods for Safeguarding Plant Immunity Response to Elevated Temperatures ORDAZ, CHRISTIAN JOSE 3d overdue
18962035 NON-INVASIVE ORTHOSIS FOR IMMOBILIZING THE CERVICAL SPINE ALBERS, KEVIN S 14d
18497368 ESTIMATING PHARMACOKINETICS OF A CONTRAST MEDIUM THROUGH A CARDIOVASCULAR SYSTEM ANALYTICAL MODEL AND/OR NEURAL NETWORK ALGORITHM FERNANDEZ, KATHERINE L 15d
17637760 COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL PAIN AND ITCH GRABER, JAMES J 15d
18080868 ENDOSCOPIC IMAGING AND PATTERNED STIMULATION AT CELLULAR RESOLUTION FERNANDEZ, KATHERINE L 16d
17766003 EPIGENETIC MODULATION OF GENOMIC TARGETS TO CONTROL EXPRESSION OF PWS-ASSOCIATED GENES LIPPOLIS, ALEXANDRA ROSE 77d
19195830 DYNAMIC 129Xe GAS EXCHANGE SPECTROSCOPY BEGEMAN, ANDREW W
18893942 KNEE IMPLANT JANOSKO, CHASITY PAIGE

Top Art Units

Art UnitApps
1631 4
1663 3
1671 3
1638 3
1632 3
1672 3
1636 3
1656 3
1683 2
3798 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19195830 DYNAMIC 129Xe GAS EXCHANGE SPECTROSCOPY BEGEMAN, ANDREW W §101§102§103§112 Non-Final OA Pending May 01, 2025
18962035 NON-INVASIVE ORTHOSIS FOR IMMOBILIZING THE CERVICAL SPINE ALBERS, KEVIN S 3786 §103 Final Rejection 14d Pending Nov 27, 2024
18893942 KNEE IMPLANT JANOSKO, CHASITY PAIGE §103§112 Non-Final OA Pending Sep 23, 2024
18759804 METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR EARLY DETECTION OF A NEURODEVELOPMENTAL OR PSYCHIATRIC DISORDER USING SCALABLE COMPUTATIONAL BEHAVIORAL PHENOTYPING AND AUTOMATED MOTOR SKILLS ASSESSMENT FRENCH, CORRELL T 3715 §101§102§103 Non-Final OA Pending Jun 28, 2024
18757189 Compositions and Methods for Safeguarding Plant Immunity Response to Elevated Temperatures ORDAZ, CHRISTIAN JOSE 1663 §101§103§112 Non-Final OA 3d overdue Pending Jun 27, 2024
18757070 THREE-DIMENSIONAL MICROSTRUCTURE PROVIDING ADDITIONAL CURRENT-CARRYING PATHWAYS FOR SENSORS RIOS RUSSO, RAUL J 2858 §103 Final Rejection 36d Pending Jun 27, 2024
18744161 COMPOSITIONS AND METHODS OF TREATING INVASIVE PATHOGENS TRAN, ERIC §102§103§112 Non-Final OA Pending Jun 14, 2024
18713948 METALLIC SINGLE-WALLED CARBON NANOTUBE HYBRID ASSEMBLIES AND SUPERSTRUCTURES THOMPSON, CAMIE S 1786 §103 Non-Final OA Pending May 28, 2024
18668784 METHOD AND SYSTEM FOR NOISE CANCELLATION BASED ON QUBIT FEEDBACK EBERSMAN, BRUCE I §103 Non-Final OA Pending May 20, 2024
18710673 COMPOSITIONS AND METHODS FOR THE MODULATION OF PIEZO1 AND TRPV4 ALAM, AYAAN A 1611 §102§103§112 Non-Final OA Pending May 16, 2024
18652899 NPR1 VARIANT TO ENHANCE PLANT RESISTANCE TO BIOTIC AND ABIOTIC STRESSES AND METHOD THEREOF ORDAZ, CHRISTIAN JOSE 1663 §112 Final Rejection Pending May 02, 2024
18639063 SYSTEMS AND METHODS FOR INCREASING THE SELECTIVITY AND EFFICACY OF SACRAL NEUROMODULATION DOWNEY, JOHN R 3792 §103 Non-Final OA Pending Apr 18, 2024
18701982 COMPOSITIONS AND METHODS RELATING TO EPIGENETIC MODULATION RAGHU, GANAPATHIRAM 1652 §101§102§103§112DP Non-Final OA Pending Apr 17, 2024
18633760 METHODS FOR REDUCING ISCHEMIA-REPERFUSION INJURIES ROZOF, TIMOTHY R 1625 §102 Non-Final OA Pending Apr 12, 2024
18700677 COMPOSITIONS COMPRISING HIV ENVELOPES TO INDUCE HIV-1 ANTIBODIES FOLEY, SHANON A DP Non-Final OA Pending Apr 11, 2024
18629894 LASOFOXIFENE TREATMENT OF BREAST CANCER PECKHAM, RICHARD GRANT §101§103§112 Non-Final OA Pending Apr 08, 2024
18697976 COMPOSITIONS COMPRISING SMALL MOLECULE REGULATORS OF TUMOR IMMUNITY AND METHODS OF USING SAME WILSON, JERICA KATLYNN 1621 §103§112 Non-Final OA Pending Apr 02, 2024
18609720 METHODS OF TREATMENT BASED ON PATIENT SPECIFIC CLINICAL TRIAL MODELS AND ASSOCIATED MODELS AND USES HEIN, DEVIN C 3686 §103 Final Rejection 14d Pending Mar 19, 2024
18581157 COMPUTATIONAL IMAGE CONTRAST FROM MULTI-DIMENSIONAL DATA BUDISALICH, ANDREW STEVEN 2662 §103 Non-Final OA Pending Feb 19, 2024
18684346 NEXT GENERATION VACCINES COMPRISING ANTIGENIC LIBRARIES AND METHODS OF MAKING AND USING SAME GILL, RACHEL B 1671 §101§102§103§112 Non-Final OA Pending Feb 16, 2024
18578262 VOLUME REDUCTION SOLIDS TREATMENT SYSTEM GURTOWSKI, RICHARD C 1773 §103 Final Rejection 49d Pending Jan 10, 2024
18575098 RADIOLABELED PARP INHIBITOR CONJUGATES FOR CANCER TREATMENT MOSHER, ERIC PARKER §102§103§112 Non-Final OA Pending Dec 28, 2023
18545176 Combination Treatment KELLY, ROBERT M §112Other Non-Final OA Pending Dec 19, 2023
18570967 COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF HEMOGLOBINOPATHIES YU, DELPHINUS DOU YI §103§112DP Non-Final OA Pending Dec 15, 2023
18532709 COMPLEMENT FACTOR H ANTIBODIES SZPERKA, MICHAEL EDWARD §101§102§112DP Non-Final OA Pending Dec 07, 2023
18511817 CHIMERIC APOPTOTIC SIGNAL TARGETING LYMPHOCYTES (TIM-4 CASTL) AND METHODS OF MAKING AND USING SAME REDDIG, PETER J §102§103§112DP Non-Final OA Pending Nov 16, 2023
18559337 HYDROGEL-COATED ORTHOPEDIC IMPLANTS NGUYEN, VI X 3771 §103 Non-Final OA 3d overdue Pending Nov 06, 2023
18499880 METHODS FOR DETECTING ONCOGENIC KRAS MUTATIONS BELLAH, JEFFREY LAWRENCE 1683 §103§112 Non-Final OA Pending Nov 01, 2023
18558203 GAS INHALATION DELIVERY DEVICES AND RELATED METHODS JANG, JAEICK 3785 §102§103§112 Non-Final OA Pending Oct 31, 2023
18558211 COMBINATION THERAPIES FOR THE TREATMENT OF CANCER RAO, SAVITHA M 1691 §102§103 Non-Final OA 10d overdue Pending Oct 31, 2023
18497368 ESTIMATING PHARMACOKINETICS OF A CONTRAST MEDIUM THROUGH A CARDIOVASCULAR SYSTEM ANALYTICAL MODEL AND/OR NEURAL NETWORK ALGORITHM FERNANDEZ, KATHERINE L 3798 §103 Non-Final OA 15d Pending Oct 30, 2023
18288817 Compositions Comprising Adeno-Associated Virus Chimera Capsid Proteins and Methods of Using the Same BURKHART, MICHAEL D 1638 §102 Non-Final OA Pending Oct 29, 2023
18376919 REGIONAL MOTION DISPLAY AND ASSESSMENT IMAGING TRAN, DUY ANH 2674 §103 Final Rejection Pending Oct 05, 2023
18552693 Compositions For and Methods of Editing the Genome MONTANARI, DAVID A 1632 §102 Non-Final OA Pending Sep 27, 2023
18551547 COMPOSITIONS AND METHODS FOR RAPID COVID-19 DETECTION CHEN, STACY BROWN 1672 §102§103§112 Non-Final OA Pending Sep 20, 2023
18550928 GENERATION OF NOVEL CRISPR GENOME EDITING AGENTS USING COMBINATORIAL CHEMISTRY OLSON, ALEXANDRA NADINE §102§103§112 Non-Final OA Pending Sep 15, 2023
18279747 SYNTHESIS AND 3D PRINTING OF TRIBLOCK COPOLYMER THROUGH ALTERNATING RING-OPENING COPOLYMERIZATION OF EPOXIDES WITH SATURATED AND UNSATURATED CYCLIC ANHYDRIDE WU, ANDREA 1763 §103 Non-Final OA Pending Aug 31, 2023
18547332 Compositions For and Methods of Improving Gene Therapy GRABER, JAMES J 1631 §102§103 Non-Final OA Pending Aug 21, 2023
18277915 NON-IMMUNOGENIC POEGMA-APTAMER CONJUGATES ZAHORIK, AMANDA MARY 1636 §103Other Non-Final OA Pending Aug 18, 2023
18274943 COMPOSITIONS COMPRISING HIV ENVELOPES TO INDUCE HIV-1 ANTIBODIES GILL, RACHEL B 1671 §102§112DP Non-Final OA Pending Jul 28, 2023
18271983 COMPOSITIONS AND METHODS FOR THE GENETIC MANIPULATION OF THE INFLUENZA VIRUS GRIZER, CASSANDRA SENN 1672 §103 Non-Final OA Pending Jul 12, 2023
18269622 COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING GLYCOGEN STORAGE DISEASES SPENCER, ANDREA LYNNE MORRIS 1631 §103§112 Non-Final OA Pending Jun 26, 2023
18036721 TOUGH, REPROCESSABLE ELASTOMERS AND METHODS OF MAKING AND USING SAME KARST, DAVID THOMAS 1767 §103 Non-Final OA Pending May 12, 2023
18033166 Compositions and Methods Relating to Alzheimer's Disease HOLLAND, PAUL J 1656 §103 Final Rejection Pending Apr 21, 2023
18033002 COMPOSITIONS FOR AND METHODS OF CO-ANALYZING CHROMATIN STRUCTURE AND FUNCTION ALONG WITH TRANSCRIPTION OUTPUT BUNKER, AMY M 1684 §103§112 Non-Final OA 23d overdue Pending Apr 20, 2023
18031313 CRISPR/CAS-BASED BASE EDITING COMPOSITION FOR RESTORING DYSTROPHIN FUNCTION JONES-FOSTER, ERICA NICOLE 1656 §102§103§112DP Non-Final OA Pending Apr 11, 2023
18030745 NOVEL TARGETS FOR REACTIVATION OF PRADER-WILLI SYNDROME-ASSOCIATED GENES HUDSON, AMY ROSE 1636 §102§103§112 Non-Final OA Pending Apr 06, 2023
18116138 CASCADED NUCLEIC ACID PROTOCOLS FOR ULTRA-SPECIFIC MOLECULAR DETECTION, TRANSDUCTION, AND AMPLIFICATION PRIEST, AARON A 1681 §102 Final Rejection Pending Mar 01, 2023
18173358 COMPOSITIONS AND METHODS FOR PROMOTING HAIR GROWTH SCHWECHTER, BRANDON ROSS 1674 §103 Non-Final OA Pending Feb 23, 2023
18042032 MICROFLUIDIC ASSAY DEVICE GIERE, REBECCA M 1677 §103§112 Non-Final OA Pending Feb 17, 2023
18107942 CROSSTALK SUPPRESSION WITH LOCAL CONTROLS STOFFA, WYATT A 2881 §112 Non-Final OA 125d overdue Pending Feb 09, 2023
18099631 SUSTAINABLE CONTINUAL LEARNING WITH DETECTION AND KNOWLEDGE REPURPOSING OF SIMILAR TASKS NGUYEN, HENRY K 2121 §101§103§112 Final Rejection Pending Jan 20, 2023
18001884 ENHANCED CELL SURVIVAL AGAINST BIOTIC AND ABIOTIC STRESSES THROUGH SALICYLICK ACID-INDUCED NPR1 CONDENSATES MCWILLIAMS, KELSEY LYNN 1663 §112 Non-Final OA 72d Pending Dec 15, 2022
18080868 ENDOSCOPIC IMAGING AND PATTERNED STIMULATION AT CELLULAR RESOLUTION FERNANDEZ, KATHERINE L 3798 §103 Final Rejection 16d Pending Dec 14, 2022
18007879 COMPOSITIONS AND METHODS FOR AUGMENTING AUTOLOGOUS FAT GRAFTS BEANE, RANDALL L 1654 §103§112 Non-Final OA 20d Pending Dec 02, 2022
17927575 COMPOSITIONS AND METHODS FOR SENSITIZING ACUTE MYELOID LEUKEMIAS TO CHEMOTHERAPY SOROUSH, ALI 1614 §103 Final Rejection 56d overdue Pending Nov 23, 2022
17921336 GENE EDITING OF SATELLITE CELLS IN VIVO USING AAV VECTORS ENCODING MUSCLE-SPECIFIC PROMOTERS LIPPOLIS, ALEXANDRA ROSE 1637 §103§112 Final Rejection Pending Oct 25, 2022
17921338 TARGETED GENOMIC INTEGRATION TO RESTORE NEUROFIBROMIN CODING SEQUENCE IN NEUROFIBROMATOSIS TYPE 1 (NF1) BRETZ, COREY LANE 1635 §103 Final Rejection 3d overdue Pending Oct 25, 2022
17921332 A HIGH-THROUGHPUT SCREENING METHOD TO DISCOVER OPTIMAL GRNA PAIRS FOR CRISPR-MEDIATED EXON DELETION DHAR, MATASHA 1632 §103§112 Final Rejection Pending Oct 25, 2022
17919111 SARS-2 SPIKE PROTEIN DESIGNS, COMPOSITIONS AND METHODS FOR THEIR USE HILL, MYRON G 1671 §112 Final Rejection Pending Oct 14, 2022
17912429 COMPOSITIONS AND METHODS FOR TREATMENT OF PATHOLOGIC PAIN ASSOCIATED WITH MALIGNANT GROWTH DISORDER MOORE, SUSANNA 1624 §103 Final Rejection Pending Sep 16, 2022
17906372 METHODS AND COMPOSITIONS FOR IMPROVED TYPE I-E CRISPR BASED GENE SILENCING HASAN, KHALEDA B 1636 DP Final Rejection Pending Sep 15, 2022
17908427 PROTEINS WITH PREDICTABLE LIQUID-LIQUID PHASE SEPARATION TSAY, MARSHA M 1656 §103§112DP Final Rejection Pending Aug 31, 2022
17908415 PROTEIN NANOPARTICLE DESIGN AND APPLICATION CARTER, SANDRA DILLAHUNT 1674 §112 Final Rejection 92d overdue Pending Aug 31, 2022
17885271 SYSTEMS AND METHODS FOR AUTOMATED SOCIAL SYNCHRONY MEASUREMENTS SITTNER, MICHAEL J 3621 §103§112 Final Rejection Pending Aug 10, 2022
17840310 METHODS FOR TREATING PAIN JOHNSON, ALLISON MARIE 1638 §103 Non-Final OA Pending Jun 14, 2022
17782112 SYSTEMS AND METHODS FOR LIPID NANOPARTICLE DELIVERY OF GENE EDITING MACHINERY YU, DAVID TUYANG 1600 §102§103 Final Rejection Pending Jun 02, 2022
17749858 UNIVERSAL LAMP ASSAYS FOR DETECTION OF NUCLEIC ACID TARGETS LU, FRANK WEI MIN 1683 §112 Final Rejection 14d Pending May 20, 2022
17774329 TREATMENT FOR PRIMARY AND METASTATIC CANCER SALVOZA, M FRANCO G 1672 §103§112 Final Rejection 24d overdue Pending May 04, 2022
17719307 ACOUSTOFLUIDIC CENTRIFUGE FOR NANOPARTICLE ENRICHMENT AND SEPARATION KUYKENDALL, ALYSSA LEE 1774 §103§112 Non-Final OA Pending Apr 12, 2022
17768454 PERIPHERALLY INSERTED LEFT VENTRICULAR VENT AND ANTICOAGULATION CATHETER SYSTEM TAYLOR, MARISSA ENVENESIA 3783 §103 Non-Final OA 9d Pending Apr 12, 2022
17768152 LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME CHENG, KAREN 1623 §102 Final Rejection 31d overdue Pending Apr 11, 2022
17766003 EPIGENETIC MODULATION OF GENOMIC TARGETS TO CONTROL EXPRESSION OF PWS-ASSOCIATED GENES LIPPOLIS, ALEXANDRA ROSE 1637 §103§112 Non-Final OA 77d Pending Apr 01, 2022
17764040 SYSTEMS AND METHODS FOR LUNG CELL EXPANSION AND DIFFERENTIATION SCHUBERG, LAURA J 1631 §103 Final Rejection Pending Mar 25, 2022
17637760 COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL PAIN AND ITCH GRABER, JAMES J 1631 §101§102§103 Non-Final OA 15d Pending Feb 23, 2022
17674212 SYSTEMS AND METHODS FOR NERVE FIBER CONDUCTION BLOCK LEE, DAVINA EN-YIN 3794 §103 Final Rejection Pending Feb 17, 2022
17603329 CRISPR/CAS-BASED GENOME EDITING COMPOSITION FOR RESTORING DYSTROPHIN FUNCTION EBBINGHAUS, BRIANA NOEL 1632 DP Final Rejection 52d overdue Pending Oct 12, 2021
17265731 Enhanced Delivery of Drugs and Other Compounds to the Brain and Other Tissues DONOGHUE, BRITTNEY ERIN 1675 §103§112Other Non-Final OA 23d overdue Pending Feb 03, 2021
17162601 FAULT CRITICALITY ASSESSMENT USING GRAPH CONVOLUTIONAL NETWORKS FACCENDA, GISEL GABRIELA 2127 §101§102§103§112 Final Rejection Pending Jan 29, 2021
17260094 BRAIN INJURY MONITORING WITH RECOVERY TRAJECTORY TAPIA, ANDREW KYLE 3687 §101§103 Non-Final OA Pending Jan 13, 2021
17007994 CONJUGATED POLYCATIONIC POLYMERS, METHODS OF USING THE SAME AND METHODS OF TREATING AUTOIMMUNE DISEASES, INFECTIOUS DISEASES AND ACUTE RADIATION EXPOSURE MEJIAS, SAMANTHA LEE 1618 §103Other Final Rejection 71d overdue Pending Aug 31, 2020
16632226 COMPOSITIONS AND METHODS COMPRISING SELF-ASSEMBLING PEPTIDE-POLYMER NANOFIBERS FOR SUBLINGUAL IMMUNIZATION STEELE, AMBER D 1658 §103§112Other Non-Final OA 4d overdue Pending Jan 17, 2020
16477110 Methods of Treating Brain Injury Using Cord Blood or a Component Thereof WILSON, MICHAEL C 1638 §103 Final Rejection Pending Jul 10, 2019

Managing Duke University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month